Cargando…
Local Delivery and Glioblastoma: Why Not Combining Sustained Release and Targeting?
Glioblastoma is one of the most aggressive brain tumors and is associated with a very low overall median survival despite the current treatment. The standard of care used in clinic is the Stupp's protocol which consists of a maximal resection of the tumor when possible, followed by radio and ch...
Autores principales: | Gazaille, Claire, Sicot, Marion, Saulnier, Patrick, Eyer, Joël, Bastiat, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757870/ https://www.ncbi.nlm.nih.gov/pubmed/35047971 http://dx.doi.org/10.3389/fmedt.2021.791596 |
Ejemplares similares
-
Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules
por: Gazaille, Claire, et al.
Publicado: (2021) -
Perfluorocarbon-Loaded Lipid Nanocapsules to Assess the Dependence of U87-Human Glioblastoma Tumor pO(2) on In Vitro Expansion Conditions
por: Lemaire, Laurent, et al.
Publicado: (2016) -
Valuing infertility treatment: Why QALYs are inadequate, and an alternative approach to cost-effectiveness thresholds
por: Keller, Elena, et al.
Publicado: (2022) -
Design and Validation of a Multi-Point Injection Technology for MR-Guided Convection Enhanced Delivery in the Brain
por: Prezelski, Kayla, et al.
Publicado: (2021) -
Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier
por: Sharma, Rohit K., et al.
Publicado: (2021)